200 related articles for article (PubMed ID: 11737307)
21. Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties.
Kanter L; Blegen H; Wejde J; Lagerlöf B; Larsson O
Melanoma Res; 1995 Oct; 5(5):345-50. PubMed ID: 8541725
[TBL] [Abstract][Full Text] [Related]
22. Unusual variants of malignant melanoma.
Magro CM; Crowson AN; Mihm MC
Mod Pathol; 2006 Feb; 19 Suppl 2():S41-70. PubMed ID: 16446716
[TBL] [Abstract][Full Text] [Related]
23. The spectrum of neurocristic cutaneous hamartoma: clinicopathologic and immunohistochemical study of three cases.
Smith KJ; Mezebish D; Williams J; Elgart ML; Skelton HG
Ann Diagn Pathol; 1998 Aug; 2(4):213-23. PubMed ID: 9845741
[TBL] [Abstract][Full Text] [Related]
24. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
25. Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study.
Kontochristopoulos GJ; Stavropoulos PG; Krasagakis K; Goerdt S; Zouboulis CC
Dermatology; 2000; 201(2):123-6. PubMed ID: 11053914
[TBL] [Abstract][Full Text] [Related]
26. Erythrophagocytic tumour cells in melanoma and squamous cell carcinoma of the skin.
Monteagudo C; Jordá E; Carda C; Illueca C; Peydró A; Llombart-Bosch A
Histopathology; 1997 Oct; 31(4):367-73. PubMed ID: 9363453
[TBL] [Abstract][Full Text] [Related]
27. Malignant primitive neuroectodermal tumor presenting as a scalp nodule.
Jacinto CM; Grant-Kels JM; Knibbs DR; Daman LA; Piorkowski RJ
Am J Dermatopathol; 1991 Feb; 13(1):63-70. PubMed ID: 2003649
[TBL] [Abstract][Full Text] [Related]
28. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
Plótár V; Szentirmay Z; Orosz Z
Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
[TBL] [Abstract][Full Text] [Related]
29. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
[No Abstract] [Full Text] [Related]
30. Small cell type malignant melanoma which developed in a 16-year-old female with a congenital dermal nevus and metastasized 12 years after excision.
Miura K; Harada H; Tsutsui Y
Pathol Int; 1999 Mar; 49(3):247-52. PubMed ID: 10338082
[TBL] [Abstract][Full Text] [Related]
31. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
[TBL] [Abstract][Full Text] [Related]
32. S100 protein and HMB-45 negative "rhabdoid" malignant melanoma: a totally dedifferentiated malignant melanoma?
Laskin WB; Knittel DR; Frame JN
Am J Clin Pathol; 1995 Jun; 103(6):772-3. PubMed ID: 7785665
[No Abstract] [Full Text] [Related]
33. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
Lohmann CM; Iversen K; Jungbluth AA; Berwick M; Busam KJ
Am J Surg Pathol; 2002 Oct; 26(10):1351-7. PubMed ID: 12360050
[TBL] [Abstract][Full Text] [Related]
34. Pigmented squamous cell carcinoma of the skin: report of two cases and review of the literature.
Jurado I; Saez A; Luelmo J; Diaz J; Mendez I; Rey M
Am J Dermatopathol; 1998 Dec; 20(6):578-81. PubMed ID: 9855353
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma.
Kocan P; Jurkovic I; Böör A; Dudríková K; Krajcár R; Benický M; Kromydaki A
Cesk Patol; 2004 Apr; 40(2):50-6. PubMed ID: 15233017
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): report of a case and review of the literature.
Patel BC; Egan CA; Lucius RW; Gerwels JW; Mamalis N; Anderson RL
J Am Acad Dermatol; 1998 May; 38(5 Pt 2):862-5. PubMed ID: 9591805
[TBL] [Abstract][Full Text] [Related]
37. Malignant melanoma developing from an intradermal nevus.
Hashiro M; Miyamoto T; Sonoda S; Okumura M
Dermatology; 1998; 196(4):425-6. PubMed ID: 9669120
[TBL] [Abstract][Full Text] [Related]
38. Congenital melanoma: a case suggesting rhabdomyogenic differentiation.
Koyama T; Murakami M; Nishihara O; Masuda T
Pediatr Dermatol; 1996; 13(5):389-93. PubMed ID: 8893239
[TBL] [Abstract][Full Text] [Related]
39. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
[TBL] [Abstract][Full Text] [Related]
40. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
